Wanghui Jing

机构：National Center for Drug Screening, Xi'an Jiaotong University · ORCID：0000-0001-9594-2989

发表论文 75 篇 · 总被引 2148 次 · h-index 23

代表论文

• Dihydromyricetin improves DSS-induced colitis in mice via modulation of fecal-bacteria-related bile acid metabolism (2021 · Pharmacological Research · 被引 206)
• Emerging pharmacotherapy for inflammatory bowel diseases (2022 · Pharmacological Research · 被引 124)
• Gut microbiota-derived tryptophan metabolites regulated by Wuji Wan to attenuate colitis through AhR signaling activation (2024 · Acta Pharmaceutica Sinica B · 被引 64)
• A mannitol-modified emodin nano-drug restores the intestinal barrier function and alleviates inflammation in a mouse model of DSS-induced ulcerative colitis (2023 · Chinese Medicine · 被引 30)
• Hyaluronic Acid-Melatonin Nanoparticles Improve the Dysregulated Intestinal Barrier, Microbiome and Immune Response in Mice with Dextran Sodium Sulfate-Induced Colitis (2022 · Journal of Biomedical Nanotechnology · 被引 21)
• Functional metabolomics revealed the dual-activation of cAMP-AMP axis is a novel therapeutic target of pancreatic cancer (2022 · Pharmacological Research · 被引 18)